Michael Bruckman/LinkedIn
Dec 17, 2025, 05:54
Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
Michael Bruckman, CEO at Haima Therapeutics, shared on LinkedIn:
”Fantastic to see platelet-inspired nanoparticles gaining attention!
This work with Case Western Reserve University and Haima Therapeutics demonstrates how targeted drug delivery at sites of injury can dramatically improve outcomes; in this case, enhancing implanted electrode performance.
Excited about the broad potential of this platform, from neuroscience to trauma care and beyond.”
Read the full article here.
Article: Platelet-inspired nanoparticle delivers drugs directly where they are needed
Authors: Julia Rock-Torcivia
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 27, 2026, 00:48Zain Khalpey: Why High quality CPR is Only Part of Successful Cardiac Arrest Management
-
Jun 26, 2026, 22:31Wendy Dusenbury: The New Issue of the Stroke Clinician is Now Live
-
Jun 26, 2026, 20:42Ed Watson: When It Happens to You, Stroke Becomes Personal, Immediate, and Life-Changing
-
Jun 26, 2026, 19:45Nathan Connell: Transforming Surgical Care with Tranexamic Acid
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders